Psychiatry news

Monash University researchers have just launched Australia’s first clinical trial to test whether the psychedelic drug psilocybin is an effective treatment for persisting post-concussion symptoms.

To celebrate Clinical Trials Day 2026, we brought our clinical and legal teams together, offering the Monash Office of the General Counsel a unique opportunity to experience the 'real-time' science behind the contracts.

A new Monash-led study by Professor Megan Galbally has found that mental health disorders are common and often overlapping in preschool children.

Congratulations to Professor Megan Galbally on receiving the 2026 Margaret Tobin Award for her outstanding leadership and impact in psychiatry.

A new perspective in Molecular Psychiatry introduces the Consortium for Preclinical Psychiatric Research, a Monash-led collaboration to accelerate translation in biological psychiatry.

Congratulations to Dr Izaak Lim from the Department of Psychiatry, School of Clinical Sciences at Monash Health, who has been awarded a Caregiving and Attachment Research and Education Collaboration Research Exchange Grant.

A new study led by Professor Megan Galbally from the School of Clinical Sciences at Monash Health and first author Dr Kelsey Perrykkad provides the largest Australian validation of the Edinburgh Postnatal Depression Scale to date.

Professor Suresh Sundram, Head of the Department of Psychiatry joins ABC’s Life Matters to discuss the clinical reality of psychedelic treatment.

Congratulations to Dr Agustin Cota Coronado who received both a Travel Award and the International Society for Stem Cell Research (ISSCR) Zhongmei Chen Yong Award for Scientific Excellenceat the ISSCR 2025 Meeting.